PH 2 Pemigatinib in SDH-deficient GIST

NCT07434843 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

SDH Gene Mutation
Gastrointestinal Stromal Tumor

Interventions

DRUG: Pemigatinib

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]